ESOPHAGEAL NEUROENDOCRINE CARCINOMA

Clinical trials for ESOPHAGEAL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ESOPHAGEAL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for ESOPHAGEAL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Major trial aims to tame dozens of rare, neglected cancers with immune power combo

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…

Matched conditions: ESOPHAGEAL NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 04, 2026 06:36 UTC

ESOPHAGEAL NEUROENDOCRINE CARCINOMA

Get alerted when new ESOPHAGEAL NEUROENDOCRINE CARCINOMA trials appear

Major trial aims to tame dozens of rare, neglected cancers with immune power combo